Anebulo Pharmaceuticals(ANEB) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

1.070
+0.050+4.90%

Close Mar 7 16:00 ET

1.070
0.0000.00%

Post 20:01 ET

43.96MMarket Cap-3.69P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Conflicted on These Healthcare Names: Anebulo Pharmaceuticals (ANEB) and AMN Healthcare Services (AMN)
TipRanksFeb 25 07:30 ET · Ratings
Express News | Anebulo Pharmaceuticals Inc Files Prospectus Related to Resale of 15.2 Mln Shares of Common Stock by Selling Stockholders- SEC Filing
ReutersFeb 20 17:26 ET
Anebulo Pharmaceuticals | 10-Q: Q2 2025 Earnings Report
SECFeb 14 16:38 ET · Announcements
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
SECFeb 14 16:23 ET · Announcements
Press Release: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
Dow JonesFeb 14 16:05 ET
Express News | Anebulo Pharmaceuticals, Inc. Q2 Operating Expenses USD 2.6 Million
ReutersFeb 14 16:05 ET

Comments

Teddy123

Feb 14 15:07

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

$Anebulo Pharmaceuticals (ANEB.US)$
Anebulo's Cannabis Overdose Treatment Gets FDA Priority Signal as Company Raises $15M

Jaguar8

Dec 23, 2024 16:05

$Anebulo Pharmaceuticals (ANEB.US)$
On December 22, 2024, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with 22NW Fund, LP (“22NW”), a greater than 5% stockholder of the Company that is controlled by Aron English, a director of the Company, as well as other institutional accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a private place...

Jaguar8

Dec 23, 2024 08:15

NEWS

$Anebulo Pharmaceuticals (ANEB.US)$
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
Monday, 23rd December at 9:15 am
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the "Company" or "Anebulo"), today announced a positive regulatory update and the close of a capital raise....

Arrayfunction

Oct 18, 2024 17:48

Starting to see how day trading can fall into the trap of gambling addiction with short selling!

Let's see if I can manage to avoid losing it all and then some next week!
After relying on just gut feeling to dump heavy into Netflix before the earnings and go to sleep.....while setting to the limit orders to sell between 720 and 730, definitely felt a bit dense
Thought I would have my revenge by shorting the peak! I've never put enough of my assets into trading to short sell (in the US, you ne...

Learn. Trade. Win: Dive into our Global Paper Trading Challenge now!

Stock_Drift

Sep 23, 2024 16:54

9/23/24’s_low life’s.

$Advent Technologies (ADN.US)$ $flyExclusive (FLYX.US)$ $Banzai International (BNZI.US)$ $Anebulo Pharmaceuticals (ANEB.US)$ $Jin Medical International (ZJYL.US)$ $ShiftPixy(Delisted) (PIXY.US)$ $Gaxos.ai (GXAI.US)$ $Scilex Holding (SCLX.US)$ $PAVmed (PAVM.US)$
📊⚡️📊

ANEB Anebulo Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks